The identification of a RNA splice variant in TULP1 in two siblings with early-onset photoreceptor dystrophy by Verbakel, S.K. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/205532
 
 
 
Please be advised that this information was generated on 2019-09-12 and may be subject to
change.
Mol Genet Genomic Med. 2019;7:e660.    |  1 of 10
https://doi.org/10.1002/mgg3.660
wileyonlinelibrary.com/journal/mgg3
Received: 27 November 2018 | Revised: 21 February 2019 | Accepted: 4 March 2019
DOI: 10.1002/mgg3.660  
O R I G I N A L  A R T I C L E
The identification of a RNA splice variant in TULP1 in two 
siblings with early‐onset photoreceptor dystrophy
Sanne K. Verbakel1  |   Zeinab Fadaie2  |   B. Jeroen Klevering1  |    
Maria M. van Genderen3,4  |   Ilse Feenstra2  |   Frans P. M. Cremers2  |    
Carel B. Hoyng1  |   Susanne Roosing2
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
1Department of Ophthalmology, Donders 
Institute for Brain, Cognition and 
Behavior, Radboud University Medical 
Center, Nijmegen, The Netherlands
2Department of Human Genetics, Donders 
Institute for Brain, Cognition and 
Behavior, Radboud University Medical 
Center, Nijmegen, The Netherlands
3Bartiméus Diagnostic Center for Complex 
Visual Disorders, Zeist, The Netherlands
4Department of Ophthalmology, University 
Medical Center Utrecht, Utrecht, The 
Netherlands
Correspondence
Susanne Roosing, Department of Human 
Genetics, Radboud University Medical 
Center, Nijmegen, The Netherlands.
Email: Susanne.Roosing@radboudumc.nl
Funding information
The work of F.P.M.C., S.R. and Z.F. is 
supported by the Foundation Fighting 
Blindness USA Project Program Award 
grant no. PPA‐0517‐0717‐RAD (to 
F.P.M.C. and S.R.). The work of F.P.M.C. 
and S.R. is also supported by the 
Rotterdamse Stichting Blindenbelangen, 
the Stichting Blindenhulp, the Stichting tot 
Verbetering van het Lot der Blinden, and 
the Stichting Blinden‐Penning (to F.P.M.C 
and S.R.).
Abstract
Background: Early‐onset photoreceptor dystrophies are a major cause of irreversible 
visual impairment in children and young adults. This clinically heterogeneous group of 
disorders can be caused by mutations in many genes. Nevertheless, to date, 30%–40% of 
cases remain genetically unexplained. In view of expanding therapeutic options, it is es-
sential to obtain a molecular diagnosis in these patients as well. In this study, we aimed to 
identify the genetic cause in two siblings with genetically unexplained retinal disease.
Methods: Whole exome sequencing was performed to identify the causative variants 
in two siblings in whom a single pathogenic variant in TULP1 was found previously. 
Patients were clinically evaluated, including assessment of the medical history, slit‐
lamp biomicroscopy, and ophthalmoscopy. In addition, a functional analysis of the 
putative splice variant in TULP1 was performed using a midigene assay.
Results: Clinical assessment showed a typical early‐onset photoreceptor dystrophy 
in both the patients. Whole exome sequencing identified two pathogenic variants in 
TULP1, a c.1445G>A (p.(Arg482Gln)) missense mutation and an intronic 
c.718+23G>A variant. Segregation analysis confirmed that both siblings were com-
pound heterozygous for the TULP1 c.718+23G>A and c.1445G>A variants, while 
the unaffected parents were heterozygous. The midigene assay for the c.718+23G>A 
variant confirmed an elongation of exon 7 leading to a frameshift.
Conclusion: Here, we report the first near‐exon RNA splice variant that is not pre-
sent in a consensus splice site sequence in TULP1, which was found in a compound 
heterozygous manner with a previously described pathogenic TULP1 variant in two 
patients with an early‐onset photoreceptor dystrophy. We provide proof of patho-
genicity for this splice variant by performing an in vitro midigene splice assay, and 
highlight the importance of analysis of noncoding regions beyond the noncanonical 
splice sites in patients with inherited retinal diseases.
K E Y W O R D S
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1 |  INTRODUCTION
Inherited retinal diseases are characterized by the progressive 
degeneration of photoreceptor and/or retinal pigment epithe-
lium cells, and are a major cause of irrecoverable visual im-
pairment. Retinitis pigmentosa (RP) encompasses the most 
common group of inherited retinal diseases, with a world-
wide prevalence of approximately 1 in 4,000 individuals 
(Pagon, 1988). RP is characterized by the rod photoreceptor 
degeneration that precedes cone photoreceptor degeneration. 
Patients generally present with night blindness, followed by 
a gradual constriction of the visual field. The visual acuity 
typically remains relatively preserved until the final stages 
of disease. Characteristic fundus features include bone spic-
ule pigmentation, attenuation of retinal vessels, and a waxy 
pallor of the optic disc. RP can follow all Mendelian pat-
terns of inheritance: autosomal dominant, autosomal reces-
sive and X‐linked. In contrast, Leber congenital amaurosis 
(LCA) is considered the most severe form of inherited retinal 
disease. It is characterized by severe loss of visual function, 
nystagmus, photophobia, amaurotic pupils (i.e., sluggish or 
near‐absent pupillary responses), high hyperopia, oculo‐dig-
ital signs such as poking, pressing, and rubbing the eyes, and 
severely reduced or absence of electroretinogram responses. 
LCA is generally inherited in an autosomal recessive manner 
(den Hollander, Roepman, Koenekoop, & Cremers, 2008; 
Weleber, Francis, Trzupek, & Beattie, 1993).
Early‐onset RP and LCA represent a continuum of retinal 
dystrophies, and are generally differentiated based on the age 
of onset; patients with an onset after infancy (variably de-
fined as age one or two) are diagnosed as having RP, while 
LCA generally presents in the first months of life (Kumaran, 
Moore, Weleber, & Michaelides, 2017). This arbitrary cut‐off 
point gives rise to large clinical and genetic overlap between 
both phenotypes. In addition, both RP and LCA display large 
clinical and genetic heterogeneity. The genetic heterogene-
ity is illustrated by the 87 genes that have been associated 
with nonsyndromic RP, and the 25 genes that are associated 
with LCA (Retnet; available at https://sph.uth.edu/retnet/) 
(Kumaran et al., 2017; Verbakel et al., 2018). Ten genes 
have been associated with both RP and LCA, among which 
TULP1 (OMIM: 602280) (Verbakel et al., 2018) .
The TULP1 gene has been associated with LCA, early‐
onset RP and cone(‐rod) dystrophy (Ajmal et al., 2012; den 
Hollander, van Lith‐Verhoeven et al., 2007; Hanein et al., 
2004; Roosing et al., 2013; Ullah et al., 2016). TULP1 en-
codes a 542‐aa (61 kDa) photoreceptor‐specific tubby‐like 
protein (i.e., tubby‐like protein‐1, TULP1) that is likely in-
volved in the transport of several phototransduction proteins 
from the photoreceptor inner segment to the outer segments, 
particularly from the opsin (e.g., rhodopsin and cone opsin) 
and guanylate cyclase carrier pathways (e.g., guanylate cy-
clase 1 and guanylate cyclase‐activating proteins 1 and 2) 
(Grossman, Watson, Pauer, Bollinger, & Hagstrom, 2011; 
Hagstrom, Watson, Pauer, & Grossman, 2012; Xi, Pauer, 
Marmorstein, Crabb, & Hagstrom, 2005).
To date, a molecular diagnosis can be identified by whole 
exome sequencing (WES) in approximately 60%–70% of RP 
and LCA patients (Haer‐Wigman et al., 2017; Kumaran et al., 
2017; Tiwari et al., 2016; Zhao et al., 2015). In the remaining 
cases, the causative variants could be located in a gene that 
has not yet been associated with early‐onset retinal dystrophies. 
Alternatively, the genetic defect could reside in a gene that has 
previously been associated with RP, but the mutation may not 
have been detected using WES because the variant resides in a 
GC‐rich region, concerns a structural variant, or was not cov-
ered for another reason. Finally, the pathogenic variant could 
have been missed because of too stringent variant filtering pro-
cedures or because it resides outside of the coding regions and 
splice sites. With the advent of therapeutic options for inherited 
retinal disorders, it becomes essential to also obtain a molecu-
lar diagnosis in patients without a conclusive genetic diagnosis.
In recent years, various studies have shown the impor-
tance of searching for variants beyond the coding and splice 
site regions. Up to 15% of LCA patients carry a deep‐in-
tronic mutation (c.2991+1655A>G) in CEP290 (Coppieters 
et al., 2010; den Hollander et al., 2006; Perrault et al., 2007) 
and these patients may benefit from an upcoming treatment 
with antisense oligonucleotides (AONs) (Dulla et al., 2018)
(ClinicalTrials.gov NCT03140969). Additionally, studies in 
Stargardt disease have identified numerous variants leading 
to an alternative splicing or pseudoexon inclusion in ABCA4 
(Albert et al., 2018). In this study, we provide evidence for 
pathogenicity of the first intronic variant outside of the splice 
site consensus sequence in TULP1, which we coin a near‐
exon aberrant RNA (NEAR) splice variant, segregating with 
a previously described pathogenic missense variant in two 
siblings with early‐onset retinal dystrophy.
2 |  METHODS
2.1 | Ethical compliance
The study adhered to the tenets of the Declaration of Helsinki 
and was approved by the local ethics committee. Written 
informed consent was obtained from both patients and their 
parents prior to inclusion in this study.
2.2 | Clinical evaluation
A family with two siblings with an autosomal recessive 
early‐onset retinal dystrophy was clinically examined at 
the Radboud university medical center in Nijmegen, the 
Netherlands. Clinical data were obtained from the medical re-
cords of the patients. Patients’ medical history was registered 
with special attention for the age at onset, initial symptoms 
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and the course of the disease. In addition, both patients were 
re‐evaluated after the identification of the genetic cause of dis-
ease. We performed a detailed ophthalmic examination, which 
included best‐corrected visual acuity, slit‐lamp biomicros-
copy, and ophthalmoscopy. Fundus photography, spectral‐
domain optical coherence tomography (SD‐OCT; Spectralis 
HRA+OCT, Heidelberg Engineering, Heidelberg, Germany), 
and fundus autofluorescence (FAF; HRA+OCT, Heidelberg 
Engineering, Heidelberg, Germany) imaging were performed. 
The visual field was assessed using a Goldmann perimeter. 
Full‐field electroretinography (ffERG) recordings were per-
formed according to the International Society for Clinical 
Electrophysiology of Vision (ISCEV) guidelines and assessed 
applying local standard values (McCulloch et al., 2015).
2.3 | Genetic analysis
Genomic DNA was extracted from peripheral lymphocytes 
according to standard procedures. WES was performed in a 
certified DNA diagnostic laboratory in both siblings (Haer‐
Wigman et al., 2017). The exome was enriched using Agilent's 
SureSelectXT Human all Exon V5 (Agilent Technologies, 
Santa Clara, CA). Subsequently, next‐generation sequencing 
using an Illumina HiSeq 4000 sequencer (Illumina, Inc. San 
Diego, CA), read alignment to the human reference genome 
(Genome Reference Consortium Human Reference 37/hg19) 
using Burrows‐Wheeler Aligner, and variant calling with the 
Genome Analysis Toolkit were performed at BGI‐Europe 
(Copenhagen, Denmark). Copy number variants were de-
tected using CoNIFER 0.2.0, and variants were annotated 
using a custom designed in‐house annotation strategy.
2.4 | Variant prioritizing
Prioritizing candidate variants for causality was based on their 
presence in both affected siblings, a minor allele frequency 
of < 0.5% in ExAC, dbSNP and the Nijmegen in‐house 
 database consisting of 15,576 individuals, their effect (i.e., 
nonsense, frameshift, canonical (donor +1 and +2,  acceptor 
−1 and −2) and noncanonical (donor +3 to +6,  acceptor −3 
to −14) splice site variants), and the occurrence in a homozy-
gous or compound heterozygous state. Moreover, for the 
remaining heterozygous variants in currently known retinal 
dystrophy‐associated genes, we manually assessed the BAM‐
files to verify if all exons (potentially harboring pathogenic 
variants) were covered.
The pathogenicity of missense variants was evaluated 
by combining in silico prediction tools, such as SIFT (http://
sift-dna.org/), PolyPhen‐2 (http://genetics.bwh.harvard.
edu/pph2/), and Mutation Taster (http://www.mutation-
taster.org/), and using the PhyloP score (range −14.1–6.4; 
predicted pathogenic ≥ 2.7) (Pollard, Hubisz, Rosenbloom, 
& Siepel, 2010), CADD‐PHRED (range 1–99; predicted 
pathogenic ≥ 15) (https://cadd.gs.washington.edu/), and 
Grantham scores (range 0–215; predicted pathogenic ≥ 80) 
(Grantham, 1974). The in silico prediction of noncanon-
ical splice variants was assessed using algorithms (i.e., 
SpliceSiteFinder‐like (Zhang, 1998), MaxEntScan (http://
genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.
html), GeneSplicer (https://www.cbcb.umd.edu/software/
GeneSplicer/gene_spl.shtml), and Human Splicing Finder 
(http://www.umd.be/HSF/) embedded in the Alamut Visual 
software version 2.10 (Interactive Biosoftware, Rouen, 
France; http://www.interactive-biosoftware.com).
2.5 | In vitro midigene splice assay
TULP1 (GenBank: NM_003322.5) is a photoreceptor‐spe-
cific protein and not expressed in available somatic cells. 
Therefore, a functional analysis of the putative splice vari-
ant c.718+23G>A in TULP1 was performed using a midi-
gene assay. We designed two midigene constructs with an 
insert of 6.3 kb, a wild‐type and mutant multi‐exon splice 
vector, using a modified protocol of the previously de-
scribed method (Figure 3).(Sangermano et al., 2016) In 
short, exon 4–11 of TULP1 of the genomic DNA from a 
control individual was amplified using forward primer 5′‐
GGAGATCCCTAGGGTGAGGA‐3′ and reverse primer: 
5′‐ATCAAAGCGAGAGGCCCTA‐3′. Both primers have 
an attB1 and attB2 tag at 5′ end to enable Gateway cloning. 
The wild‐type construct served as a template to generate the 
mutant construct of c.718+23G>A by mutagenesis PCR. 
Subsequently, wild‐type and mutant constructs were incor-
porated into the pCI‐NEO‐RHO Gateway‐adapted vector as 
previously described.(Sangermano et al., 2016) This resulted 
in a wild‐type midigene c.718+23G and a mutant midigene 
c.718+23A. Finally, we transfected HEK293T cells with 
the wild‐type or mutant midigene and studied the transcripts 
with reverse transcription–polymerase chain reaction with 
primers in exons 4 and 11 (RT‐PCR) (Forward primer: 5′‐
GTCTACGCCAGGTTCCTCAG‐3′ and Reverse primer: 
5′‐TCCTCGGGACAGATTGGTAG‐3′).
3 |  RESULTS
3.1 | Clinical findings
Figure 1 shows the pedigree of the two siblings we studied, 
both were from Dutch ancestry and presented with a retinal 
dystrophy that we classified as very early‐onset forms of RP. 
An overview of the clinical characteristics at the most recent 
examination is provided in Table 1. The eldest patient, in-
dividual II:1, presented with a fine horizontal nystagmus at 
the age of three. Subsequently, he developed night blindness 
that became apparent at the age of five. His visual acuity 
gradually deteriorated from 20/50 at age five to 20/100 when 
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he was 15 years of age. His younger sister (patient II:2) pre-
sented with a subtle horizontal nystagmus at the age of one. 
Her visual acuity deteriorated from 20/50 at the age of three 
to 20/60 at age 13, and she also experienced impaired night 
vision in early childhood. At the most recent examination, 
both siblings complained of photophobia. In addition, pa-
tient II:1 reported photopsias, particularly after a sudden in-
crease in light intensity. Perimetry showed constriction of 
the visual field from age 11 in patient II:1, with a central 
island measuring up to 10 degrees at the age of 15 years. 
In patient II:2, the constriction of the visual field started at 
age 10 and progressed to a constriction up to 20–30 degrees 
at the age of 13 years. High hyperopia was present in both 
siblings, with spherical equivalent refractions ranging from 
6.13 to 7.25. Both siblings were in good general health, and 
no extra‐ocular conditions were reported.
Ophthalmoscopy showed peripheral bone spicule pig-
mentation, attenuated retinal vessels, and small hyperemic 
optic discs (often found in high hyperopia) in both siblings 
(Figure 2). Fundus autofluorescence imaging revealed the 
characteristic hyperautofluorescent ring that represents the 
transition zone between intact and degenerated photorecep-
tor outer segments. This was confirmed by SD‐OCT images 
that showed an intact ellipsoid zone layer inside the ring, 
and loss of the outer retinal layers outside of the hyperaut-
ofluorescent ring area. In addition, the SD‐OCT image re-
vealed diffuse thickening of the retina in patient II:1, which 
proved refractory to treatment with 125 mg oral carbonic 
anhydrase inhibitors three times a day. Cystoid macular 
edema was identified in patient II:2 at age 11. However, in 
her case, the cystoid macular edema revolved after treatment 
with carbonic anhydrase inhibitors, and did not recur—or at 
least in a severely reduced fashion—after sustained treatment 
with 125 mg oral carbonic anhydrase inhibitors two times a 
day. Electrophysiological examination at the age of five (pa-
tient II:1) and six (patient II:2) demonstrated a generalized 
F I G U R E  1  Pedigree of the family included in this study. The 
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photoreceptor dystrophy with severely affected photoreceptor 
responses in a rod‐cone pattern.
3.2 | Genetic findings
Initial analysis of WES data in patient II:1 detected two 
heterozygous variants, a c.1445G>A (p.(Arg482Gln)) mis-
sense variant in TULP1 and a c.1567C>T (p.(Arg523*)) 
nonsense variant in FAM161A. Subsequently, WES was 
performed in patient II:2; she also carried the heterozy-
gous missense variant in TULP1, as well as a heterozy-
gous c.3683A>G (p.(Tyr1228Cys)) missense variant in 
RPGRIP1. All coding regions of TULP1 were covered in 
the WES data of both siblings, and uncovered exons from 
RPGRIP1 and FAM161A were Sanger sequenced but did 
not reveal additional putative pathogenic variants in either 
sibling. Moreover, no copy number variants were identified 
in FAM161A, RPGRIP1 or TULP1 in both individuals. As 
the FAM161A and RPGRIP1 pathogenic variant were not 
shared between the siblings, we pursued to study TULP1 in 
more detail. The previously described variant c.1445G>A 
(p.(Arg482Gln) has a CADD‐Phred score of 23.2, a PhyloP 
score of 6.1, and a Grantham score of 43. (Ajmal et al., 
2012) An expanded analysis beyond the coding regions 
and putative splice site regions resulted in the identifica-
tion of a heterozygous intronic variant, c.718 + 23G>A 
(Figure 3), found in both siblings. Segregation analysis 
confirmed that both siblings were compound heterozygous 
for the c.718+23G>A and c.1445G>A variants, while the 
unaffected parents were heterozygous (Figure 1). Although 
the c.718+23G>A variant, based on splice score predic-
tion algorithms, does not alter the nearby splice donor 
site, this deep‐intronic variant increased the splice predic-
tion scores at position c.718 + 20 when using programs 
SpliceSiteFinder‐like (+4.4%), MaxEntScan (+33.33%), 
GeneSplice (+12.5%), and Human Splicing Finder (+1.1%) 
(Figure 3). Additionally, c.718+23G>A introduced a new 
exonic splice enhancer (ESE) motif recognized by the 
SC35 exonic splice enhancer at the c.718+21 to c.718+29 
positions where a putative splice donor site is already lo-
cated in the wild‐type mRNA, and reduces the number and 
strength of exonic splice silencer (ESS) motifs present in 
the reference sequence.
3.3 | In vitro midigene splice assay
Reverse transcription polymerase chain reaction showed the 
expected 832‐bp wild‐type fragment (Figure 3). In contrast, 
F I G U R E  2  Multimodal images of both siblings. (a–c) Multimodal imaging of the left eye of patient II:1 at the age of 15 years. (a) Composite 
fundus photograph showing a hyperemic optic disc, sparse bone spicule pigmentation in the periphery, and slightly attenuated vessels. (b) 30° 
fundus autofluorescence image revealing a characteristic hyperautofluorescent ring, (c) which corresponds to preservation of the ellipsoid zone 
within the ring, as visible on spectral‐domain optical coherence tomography (SD‐OCT). In addition, SD‐OCT imaging also showed a thickened 
retina. (d‐f) Multimodal imaging of the left eye of patient II:2 at the age of 13 years. (d) Composite fundus photograph showing a small and 
hyperemic optic disc, attenuation of the retinal vessels, and bone spicule pigmentation in the periphery. (e) 55° fundus autofluorescence image 
showing a central hyperautofluorescent ring. (f) The SD‐OCT scan reveals preserved photoreceptor layers at the fovea, and multiple small 
intraretinal cysts
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the mutant midigene showed a product that corresponds to 
a larger fragment, and absence of the wild‐type fragment. 
Sanger sequencing verified that the mutant mRNA product 
contained a 20‐nucleotide elongation of exon 7, which can 
be explained by the use of a cryptic splice donor site 20 nu-
cleotides downstream of exon 7 (Figure 3). This elongation 
causes a frameshift and results in early protein truncation 
(p.(Thr241Glyfs*23)).
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4 |  DISCUSSION
In the present study, we identified a near‐exon aberrant RNA 
splice variant that we termed a “NEAR” splice variant in 
TULP1 in trans with a previously described exonic variant 
in two siblings with early‐onset RP. Both siblings showed 
a nystagmus, night blindness, and a reduced visual acuity 
early in life. Fundus examination at the age of 15 (patient 
II:1) and 13 years (patients II:2) showed bone spicule pig-
mentation, attenuation of the retinal vessels and a small, hy-
peremic optic disc. High hyperopia (i.e., refractive error of 
more than +5.00 D) was present in both siblings. TULP1‐as-
sociated disease has previously been associated with myopia 
(den Hollander, Lopez et al., 2007; den Hollander, van Lith‐
Verhoeven et al., 2007; Hendriks et al., 2017; Souzeau et al., 
2018) and hyperopia (den Hollander, Lopez et al., 2007; 
Khan, Bergmann, Eisenberger, & Bolz, 2015). However, 
high hyperopia has only been described in patients with 
LCA, and is thought to result from impaired emmetropization 
caused by early‐onset visual impairment (Khan et al., 2015; 
Weleber et al., 1993).
Both siblings were diagnosed with early‐onset RP based 
on an onset after the age of one. However, they also show 
characteristic aspects of LCA such as a nystagmus and hyper-
opia. The difficulty in classifying such patients arises from 
the strict and rather arbitrary separation of both entities, when 
in fact they represent a continuum of retinal dystrophies.
Thus far, three noncanonical splice site variants in 
the TULP1 gene (i.e., c.999+5G>C, c.1224A>G, and 
c.1496‐6C>A) have been reported in patients with TULP1‐
associated disease (den Hollander, Lopez et al., 2007; Gu 
et al., 1998; Hagstrom, North, Nishina, Berson, & Dryja, 
1998). We identified two pathogenic variants in TULP1, a 
c.1445G>A (p.(Arg482Gln)) missense mutation and an in-
tronic c.718+23G>A variant. The TULP1 p.(Arg482Gln) 
mutation, previously described in patients with early‐onset 
RP, alters the structure and function of the Tubby domain, and 
is expected to affect TULP1 function (Ajmal et al., 2012). To 
our knowledge, pathogenicity of mutations in TULP1 such as 
the c.718+23G>A variant, which we coin as a NEAR splice 
variant, has not been described before. Our definition of a 
NEAR splice variant is a variant located outside of the splice 
site consensus sequence leading to an alteration of the splic-
ing of a nearby exon, whereas a deep‐intronic variant often 
leads to the inclusion or alteration of a cryptic exon.
The consequence of a NEAR splice variant depends on the 
context of the variant, such as the strength of nearby splice 
acceptor and splice donor sites, the presence and size of 
flanking exons, and the effect on the appearance or removal 
of ESE, ESS, intronic splice enhancer, and intronic splice si-
lencer motifs. To assess the effect of this variant on splicing, 
we generated a midigene assay which contained exon 4 to 11 
of TULP1. This analysis showed the use of a cryptic splice 
donor site 20 bp downstream, which causes a shift of the 
reading frame resulting in early termination of protein syn-
thesis. The severe nature of the c.718+23G>A NEAR splice 
variant is supported by the absence of a wild‐type fragment in 
cells transfected with the mutant midigene and corresponds 
with the severe phenotype observed in the patients.
The donor splice site of exon 7 of the TULP1 gene con-
tains a fairly weak splice site as indicated by the score of 77.4 
for Human Slicing Finder. A natural stronger cryptic splice 
donor site is present at the c.718+20 position in the wild‐type 
mRNA with a score of 83.4 for the Human Splicing Finder 
prediction (Tang, Prosser, & Love, 2016). The presence of 
ESSs located in and near the c.718+20 position likely explain 
why the cryptic donor site is not utilized by the splice ma-
chinery in wild‐type cells. The c.718+23G>A variant, how-
ever, shows a decreased number of ESSs in this region, and 
consequently enables recognition of the putative splice donor 
site by the spliceosome (http://www.umd.be/HSF3/). In addi-
tion, according to ESE predictions, this variant also creates 
a new binding site for exonic splice enhancer SC35 at the 
c.718+21 to c.718+29 positions that strengthens this putative 
splice donor site and generates preference for the c.718+20 
donor instead of the canonical splice donor site. This sup-
ports the role of ESEs and ESSs in the splicing process, and 
highlights the importance of these factors when analyzing the 
pathogenicity of variants within or outside of the coding and 
splice site regions.
F I G U R E  3  Molecular genetic characterization of the splice effect of the c.718+23G>A variant in TULP1. (a) Schematic representation 
of the TULP1 gene and enlargement of the wild‐type and mutant DNA sequences at the exon–intron boundary of exon 7 of TULP1. The 
SpliceSiteFinder‐like (SSFL, range 0–100), MaxEntSCan (MES, range 0–12), GeneSplicer (GS, range 0–24) and Human Splicing Finder (HSF, 
range 0–100) scores for the splice donor site are indicated above the gene. The red “A” highlights the variant c.718+23G>A identified in both 
siblings. The red numbers represent altered scores compared to the wild-type. The green circle implies a newly recognized SC35 motif. Dotted 
circles indicate exonic splice silencers no longer present by prediction tools (b) Schematic representation of the mutant pCI‐NEO‐RHO vector, 
containing exon 4–11 of the TULP1 gene used to transfect HEK293T cells with a wild‐type or mutant midigene. (c) RT‐PCR products of the 
wild‐type and mutant midigene showing the expected 832‐bp wild‐type fragment and a 852‐bp fragment of the mutant midigene corresponding to 
a 20‐nucleotide elongation of the mRNA encoded by exon 7. The wild‐type fragment was absent in the cells transfected with the mutant midigene. 
RT‐PCR analysis of RHO exon 5 was performed as a control for efficient transfection. (d) Sanger sequence analysis of the RT‐PCR fragments 
confirmed the wild‐type and the 20‐bp elongation of exon 7 in the mutant
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While this is the first intronic variant outside of the splice 
site consensus sequences deemed pathogenic in TULP1, the 
causality of deep‐intronic variants has also been described in 
nine other retinal dystrophy genes: ABCA4, CEP290, CHM, 
OA1, OAT, OFD1, PROM1, PRPF31, and USH2A (Bax et al., 
2015; Braun et al., 2013; Carss et al., 2017; den Hollander 
et al., 2006; Liquori et al., 2016; Mayer et al., 2016; Naruto 
et al., 2015; Rio Frio et al., 2009; Vache et al., 2012; van 
den Hurk et al., 2003; Webb et al., 2012) (www.dbass.soton.
ac.uk). Intronic variants are likely to explain a substantial 
portion of the current genetically unexplained or monoallelic 
retinal dystrophy cases, and underscore the importance of ge-
netic tests uncovering those regions, such as whole genome 
sequencing. Future studies with whole genome sequencing 
will likely increase the number of genetically solved patients. 
However, the increase in the use of whole genome sequenc-
ing will be accompanied by the detection of a large number of 
variants of unknown significance, and determining the func-
tional role of these variants will remain a challenge.
The identification of biallelic variants in patients with 
a retinal dystrophy is essential for eligibility for upcoming 
genetic therapies. Besides gene augmentation therapy, pa-
tients with a TULP1 NEAR splice variant may benefit from 
AONs treatment, which can suppress the aberrant splicing 
effect by binding to the mutated region in the pre‐mRNA. 
To date, proof‐of‐concept of AONs has been shown in both 
cell‐based models and animal models for four retinal dystro-
phy genes: CEP290 (Collin et al., 2012; Dulla et al., 2018; 
Garanto et al., 2016; Parfitt et al., 2016), CHM (Garanto, van 
der Velde‐Visser, Cremers, & Collin, 2018), RHO (Murray 
et al., 2015), and USH2A (Slijkerman et al., 2016), and rep-
resents a promising therapy for retinal dystrophies (Collin & 
Garanto, 2017).
In conclusion, we identified a pathogenic NEAR splice 
variant in TULP1 in trans with a known pathogenic missense 
variant in two siblings with an early‐onset photoreceptor dys-
trophy in whom analysis of the exonic and consensus splice 
site regions did not identify the cause of disease. This high-
lights the importance of investigating noncoding regions in 
order to obtain a conclusive molecular diagnosis in patients 
with a hereditary retinal dystrophy.
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